# Institute for Reproductive Health – FDA Inspection, Aug 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/institute-for-reproductive-health/d852e441-f957-4f83-be82-bcbfed8a5eb0
Source feed: FDA_Inspections

> FDA inspection 1216366 of Institute for Reproductive Health, August 30, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 1271. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216366
- Company Name: Institute for Reproductive Health
- Inspection Date: 2023-08-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1296650 - 2025-12-17
- FDA Inspection 1269958 - 2025-05-15
- FDA Inspection 1146177 - 2021-07-14
- FDA Inspection 1053319 - 2018-05-23
- FDA Inspection 971871 - 2016-05-25

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jennifer-l-sheehan/a49c628d-6eba-4b52-bafc-70785b9ba75e)

Company: https://www.keypedia.com/companies/institute-for-reproductive-health/ceba79db-8deb-4769-ace2-9310a1125be2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d